Transarterial Chemoperfusion: Cisplatin, Methotrexate, Gemcitabine for Unresectable Pleural Mesothelioma
Clinical trial NCT02611037 · COMPLETED
Trial details
- NCT number
- NCT02611037
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-04
- Primary completion
- 2021-10-16
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.